Akshay Vaishnaw
Board of Directors
Diagnosezentrum Donaustadt
Liechtenstein
Biography
In his 7 years at Biogen, Dr. Vaishnaw was involved in many aspects of clinical research and business development, and led the effort for the approval of AMEVIVE® (alefacept) for psoriasis.
Research Interest
Pharmaceutical
